IMR Press / EJGO / Volume 5 / Issue 1 / pii/1984010

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

Topical testosterone propionate in the therapy of vulvar dystrophies

Show Less
1 Obstetric and Gynecologic Institute, University of Padua, Italy
2 Obstetric and Gynecologic Institute, University of Sassari, Italy
Eur. J. Gynaecol. Oncol. 1984, 5(1), 58–63;
Published: 10 February 1984

187 patients with atrophic, hypertrophic and mixed vulvar dystrophy were treated with 2% testosterone propionate ointment from 18 months to 7 years. Symptoms, macroscopic, and histologic picture were evaluated before and during treatment. About 75% of the patients achieved good and excellent symptom relief. Treatment efficacy differentiates according to the type of dystrophy, and in relation to the lesion’s extension and the duration of symptoms, which consist mostly of pruritus. Side effects from therapy were negligible.

Vulvar dystrophies
Testosterone propionate
Back to top